Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01142466
Brief Title: A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone (REMAIN)

First Submitted : June 10, 2010
First Submitted that Met QC Criteria : June 10, 2010
First Posted : June 11, 2010 (Estimate)

Results First Submitted : April 7, 2011
Results First Submitted that Met QC Criteria : May 11, 2011
Results First Posted : June 10, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : January 26, 2014
Last Update Posted : February 27, 2014 (Estimate)